Abstract:MYC family oncoproteins regulate the expression of a large number of genes and broadly stimulate elongation by RNA polymerase II. While the factors that control the chromatin association of MYC proteins are well understood, much less is known about how interacting proteins mediate MYC's effects on transcription. Here we show that TFIIIC, an architectural protein complex that controls the three-dimensional chromatin organization at its target sites, binds directly to the amino-terminal transcriptional regulatory domain of MYCN. Surprisingly, TFIIIC has no discernible role in MYCN- dependent gene expression and transcription elongation. Instead, MYCN and TFIIIC preferentially bind to promoters with paused RNAPII and globally limit the accumulation of non-phosphorylated RNAPII at promoters. Consistent with its ubiquitous role in transcription, MYCN broadly participates in hubs of active promoters. Depletion of TFIIIC further increases MYCN localization to these hubs. This increase correlates with a failure of the nuclear exosome and BRCA1, both of which are involved in nascent RNA degradation, to localize to active promoters. Our data suggest that MYCN and TFIIIC exert an censoring function in early transcription that limits promoter accumulation of inactive RNAPII and facilitates promoter-proximal degradation of nascent RNA.

What problem does this paper attempt to address?

This paper mainly explored the interaction between MYCN and TFIIIC and its impact on gene transcription regulation. Specifically, the researchers attempted to address the following issues: 1. **Direct interaction between MYCN and TFIIIC**: - The researchers experimentally verified that the amino - terminal transcriptional regulatory region of MYCN can directly bind to TFIIIC. This finding was confirmed by the recombinant expression system and pull - down experiments. 2. **The role of TFIIIC in MYCN - dependent gene expression**: - Although MYCN and TFIIIC are co - localized on many promoters, TFIIIC does not seem to directly affect MYCN - dependent gene expression or transcription elongation. Instead, they jointly limit the accumulation of non - phosphorylated RNA polymerase II (RNAPII) on the promoter. 3. **MYCN participates in the three - dimensional chromatin network**: - The researchers used the pLHiChIP technique to analyze the role of MYCN in the three - dimensional chromatin structure and found that MYCN is widely involved in the three - dimensional network of active promoters (referred to as "promoter - centric"). These networks connect many active promoters, especially those encoding ribosomal proteins and ribosome biogenesis genes. 4. **TFIIIC counteracts the positioning of MYCN in the promoter - centric**: - The experimental results showed that the presence of TFIIIC counteracts the positioning of MYCN in the promoter - centric. When TFIIIC is depleted, the positioning of MYCN in the promoter - centric significantly increases, indicating that TFIIIC restricts this positioning of MYCN to a certain extent. 5. **The censorship function of TFIIIC in early transcription**: - The researchers further discovered that TFIIIC plays a censorship function in early transcription, limiting the accumulation of non - functional RNAPII on the promoter and promoting the degradation of nascent RNA near the promoter. This involves the influence of TFIIIC on the positioning of the nuclear exosome and BRCA1. In summary, this paper attempts to reveal the complex interaction between MYCN and TFIIIC and its specific mechanisms in gene transcription regulation, especially in terms of limiting the accumulation of non - functional RNAPII and promoting the degradation of nascent RNA. These findings contribute to a deeper understanding of the regulatory mechanisms of MYCN in cell growth, proliferation, and differentiation, as well as its potential role in cancer development.

Association with TFIIIC limits MYCN localization in hubs of active promoters and chromatin accumulation of non-phosphorylated RNA Polymerase II

Association with TFIIIC limits MYCN localisation in hubs of active promoters and chromatin accumulation of non-phosphorylated RNA polymerase II

Mechanism of Interaction Between the Transactivation Domain of N-MYC and the DNA-Binding Surface of TFIIIC5

A Positive Feedback Loop Between EBP2 and C-Myc Regulates Rdna Transcription, Cell Proliferation, and Tumorigenesis.

RNA-mediated MYC multimerization suppresses innate immune signaling

The MYCN oncoprotein is an RNA-binding accessory factor of the nuclear exosome targeting complex

MYC Binding Near Transcriptional End Sites Regulates Basal Gene Expression, Read-Through Transcription and Intragenic Contacts

A New Insight into MYC Action: Control of RNA Polymerase II Methylation and Transcription Termination

MYC Promotes Global Transcription in Part by Controlling P-TEFb Complex Formation Via DNA-binding Independent Inhibition of CDK9 SUMOylation

MYC phase separation selectively modulates the transcriptome

MYC Protein Inhibits Transcription of the MicroRNA Cluster MC-let-7a-1∼let-7d Via Noncanonical E-box

MYC shapes ER-mitochondria calcium transfer by directly targeting : implications for MYC-induced safeguard mechanisms and cancer

MYCN drives oncogenesis by cooperating with the histone methyltransferase G9a and the WDR5 adaptor to orchestrate global gene transcription

Phase Separation of Myc Differentially Modulates the Transcriptome

Acute depletion of CTCF directly affects MYC regulation through loss of enhancer–promoter looping

Uncoupling the TFIIH Core and Kinase Modules Leads To Misregulated RNA Polymerase II CTD Serine 5 Phosphorylation

Target gene-independent functions of MYC oncoproteins

Abstract PR06: the Enhancer Landscape Involves a Core Noncoding RNA Protein Interaction Network Forc-Mycexpression

A trimeric USP11/USP7/TCEAL1 complex stabilizes RNAPII during early transcription to sustain oncogenic gene expression

MYC dephosphorylation by the PP1/PNUTS phosphatase complex regulates chromatin binding and protein stability

Functional interactions among members of the MAX and MLX transcriptional network during oncogenesis